Results 81 to 90 of about 4,888 (188)

Essential medications in palliative care: an updated survey of Australian and New Zealand medical practitioners practising palliative care

Internal Medicine Journal, Volume 56, Issue 8, Page 1361-1368, August 2026.
Abstract Background Palliative care patients experience complex symptoms requiring varied pharmacological management. Medication choice depends on the underlying aetiology of symptoms, guideline recommendations, clinician preference and medication availability.
Jack Power, Tim Luckett, Richard McNeill, David Currow, Amanda Landers, Gregory B. Crawford, Slavica Kochovska, Philip Good, Jessica Boyley, Sungwon Chang, Lisa Mounsey   +10 more
wiley   +1 more source

Consumption patterns before and during the COVID-19 pandemic among patients admitted to inpatient drug detoxification treatment: Results of two cross-sectional surveys from 2018 and 2021

Frontiers in Psychiatry
BackgroundThe lockdown measures during the SARS-CoV-2 pandemic could have influenced drug consumption patterns of persons with drug use disorder, especially due to a reduced availability of drugs, an increased consumption of sedating substances as a ...
Patrik Roser, Patrik Roser, Michael Specka, Udo Bonnet, Udo Bonnet, Thomas Kuhlmann, Stefan Kühnhold, Renate Steinert, Benita Zeiske, Daniel Deimel, Daniel Deimel, Norbert Scherbaum   +11 more
doaj   +1 more source

Effectiveness and Tolerability of Topical Amitriptyline 10% Plus Lidocaine 2% Gel in Adults With Post‐Traumatic Trigeminal Neuropathic Pain: A Real‐World Evidence Study

Journal of Oral Rehabilitation, Volume 53, Issue 8, Page 1550-1561, August 2026.
A compounded amitriptyline 10% plus lidocaine 2% mucoadhesive gel was associated with substantial pain improvement and favourable tolerability in adults with post‐traumatic trigeminal neuropathic pain (PTNP). These findings support targeted mucosal delivery as a promising practical local option and a potential medication‐sparing strategy, particularly ...
Ashley Lebel, Imen Stambouli, Yves Boucher   +2 more
wiley   +1 more source

Comparative Effectiveness of Opioids and Opioid Substitutes on Pain and Health Related Quality of Life Among Cancer Survivors

Cancer Medicine
Introduction Chronic pain is a major but modifiable contributor to poor quality of life among long‐term cancer survivors. With growing concern over opioid‐related risks, gabapentinoids have emerged as a safer alternative, though evidence comparing their ...
Shirley K. Chan Sanchez, Samuel V. David, Efstathia Polychronopoulou, Mukaila Raji, Yong‐Fang Kuo   +4 more
doaj   +1 more source

Wherefore Gabapentinoids? [PDF]

Anesthesiology, 2016
Evan D, Kharasch, James C, Eisenach
openaire   +2 more sources

Gabapentinoids in the perioperative period [PDF]

Anesteziologie a intenzivní medicína, 2021
O Gimunová, J Zemanová
openaire   +1 more source

Non-opioid psychiatric medications for chronic pain: systematic review and meta-analysis

Frontiers in Pain Research
BackgroundThe escalating number of deaths related to opioid usage has intensified the pursuit of non-opioid alternatives for managing chronic pain. It's often observed that psychiatric comorbidities coexist in patients suffering from chronic pain.
Shahana Ayub, Anil Krishna Bachu, Lakshit Jain, Shanli Parnia, Siddhi Bhivandkar, Rizwan Ahmed, Jasleen Kaur, Surya Karlapati, Sakshi Prasad, Hansini Kochhar, Oghenetega Esther Ayisire, Saloni Mitra, Bikona Ghosh, Sushma Srinivas, Sahar Ashraf, Bhavani Nagendra Papudesi, Palash Kumar Malo, Shoib Sheikh, Shoib Sheikh, Michael Hsu, Domenico De Berardis, Saeed Ahmed   +21 more
doaj   +1 more source

Trends in Co-Prescribing Opioids and Gabapentinoids Among Medicare Beneficiaries, 2017 to 2022

Medical Sciences
Background: Co-prescribing opioids and gabapentinoids (GABA, gabapentin and pregabalin) is associated with increased risk of falls, fractures, opioid overdose and deaths.
Mukaila Raji, Aashnika Sujit, Jordan Westra, Shilpa Rajagopal, Yong-Fang Kuo   +4 more
doaj   +1 more source

Association Between the Use of Gabapentinoids and Exacerbations of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-analysis

Current Therapeutic Research
Background: Evidence on gabapentinoids and its respiratory safety among the patients with chronic obstructive pulmonary disease(COPD) or asthma are remains uncertain. Objective: To evaluate the risk of exacerbations with gabapentinoids.
Ranakishor Pelluri, MPharm, PhD, Lalasa Sri Tulasi Royyuru, PharmD, Suresh Varukolu, MPharm, Paul Kitonga Muteti, BPharm, Birungi Mariam Nalukenge, BPharm, Sravani Thommandru, PharmD, Buchi Naidu Nalluri, MPharm, PhD, Prasada Chowdari Gurram, MPharm, PhD, Bhima Sridevi, MPharm, PhD, Blessy Chittelu, PharmD, Vanitha Rani Nagasubramanian, MPharm, PhD, Uday Venkat Mateti, PharmD, PhD, Ananthesh L, MPharm, Ramya Rachamanti, MBBS, MD, Nageswari Patnam, MPharm, PhD, Kannan Gopal, MPharm, PhD   +15 more
doaj   +1 more source

Pain And The Use Of Gabapentinoids In German Nursing Home Residents - Results From An Analysis Based On Statutory Health Insurance Data

Journal of Pain Research, 2019
C Bantel,1,2 F Hoffmann,3 K Jobski3 1Department of Anesthesiology, Critical Care, Emergency and Pain Medicine, Universität Oldenburg, Klinikum Oldenburg, Oldenburg, Germany; 2Department of Surgery & Cancer, Anaesthetics Section, Imperial College
Bantel C, Hoffmann F, Jobski K
doaj